BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10721864)

  • 41. Cumulative effects from repeated exposures to suberythemal doses of UVB and UVA in human skin.
    Lavker RM; Gerberick GF; Veres D; Irwin CJ; Kaidbey KH
    J Am Acad Dermatol; 1995 Jan; 32(1):53-62. PubMed ID: 7822517
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Study of action spectrum of papulovesicular light eruption (PVLE)].
    Miyamoto C; Keong CH; Satoh Y
    Nihon Hifuka Gakkai Zasshi; 1990 Apr; 100(5):581-7. PubMed ID: 2395220
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Narrow-band UVB (TL-01) phototherapy: an effective preventative treatment for the photodermatoses.
    Collins P; Ferguson J
    Br J Dermatol; 1995 Jun; 132(6):956-63. PubMed ID: 7662575
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Photoprovocation test and immunohistochemical analysis of inducible nitric oxide synthase expression in patients with Sjögren's syndrome associated with photosensitivity.
    Tsukazaki N; Watanabe M; Shimizu K; Hamasaki Y; Katayama I
    Br J Dermatol; 2002 Dec; 147(6):1102-8. PubMed ID: 12452858
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Histopathology of photodermatoses].
    Megahed M; Schaller J
    Hautarzt; 2006 Dec; 57(12):1083-8. PubMed ID: 17093995
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Polymorphous light eruption: the properties of a UVA-induced PLME patient group.
    McFadden N; Larsen TE
    Photodermatol; 1986 Feb; 3(1):36-40. PubMed ID: 3703701
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of a Daily Protective Moisturizer with High UVB and UVA Photoprotection in Decreasing Ultraviolet Damage: Evaluation by Reflectance Confocal Microscopy.
    Gomes-Neto A; Aguilera P; Prieto L; Seité S; Moyal D; Carrera C; Malvehy J; Puig S
    Acta Derm Venereol; 2017 Nov; 97(10):1196-1201. PubMed ID: 28661544
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Correlation of serum IgE levels and clinical manifestations in patients with actinic prurigo.
    Cuevas-Gonzalez JC; Lievanos-Estrada Z; Vega-Memije ME; Hojyo-Tomoka MT; Dominguez-Soto L
    An Bras Dermatol; 2016; 91(1):23-6. PubMed ID: 26982774
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of topical cyclosporin for conjunctival manifestations of actinic prurigo.
    McCoombes JA; Hirst LW; Green WR
    Am J Ophthalmol; 2000 Dec; 130(6):830-1. PubMed ID: 11124306
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A case of actinic prurigo and solar urticaria.
    Yu RC; King CM; Vickers CF
    Clin Exp Dermatol; 1990 Jul; 15(4):289-92. PubMed ID: 2208779
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Polymorphic light eruption.
    Norris PG; Hawk JL
    Photodermatol Photoimmunol Photomed; 1990 Oct; 7(5):186-91. PubMed ID: 2091741
    [TBL] [Abstract][Full Text] [Related]  

  • 52. What is actinic prurigo in Britain?
    Grabczynska SA; Hawk JL
    Photodermatol Photoimmunol Photomed; 1997 Jun; 13(3):85-6. PubMed ID: 9372521
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Photosensitivity in infants and children.
    Bligard CA; Storer JS
    Dermatol Clin; 1986 Apr; 4(2):311-9. PubMed ID: 3955901
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential expression of melanoma-associated growth factors in keratinocytes and fibroblasts by ultraviolet A and ultraviolet B radiation.
    Brenner M; Degitz K; Besch R; Berking C
    Br J Dermatol; 2005 Oct; 153(4):733-9. PubMed ID: 16181453
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sunscreens containing the broad-spectrum UVA absorber, Mexoryl SX, prevent the cutaneous detrimental effects of UV exposure: a review of clinical study results.
    Fourtanier A; Moyal D; Seité S
    Photodermatol Photoimmunol Photomed; 2008 Aug; 24(4):164-74. PubMed ID: 18717957
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibitory effect of polypeptide from Chlamys farreri on ultraviolet A-induced oxidative damage on human skin fibroblasts in vitro.
    Han YT; Han ZW; Yu GY; Wang YJ; Cui RY; Wang CB
    Pharmacol Res; 2004 Mar; 49(3):265-74. PubMed ID: 14726223
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Failure of physiologic doses of pure UVA or UVB to induce lesions in photosensitive cutaneous lupus erythematosus: implications for phototesting.
    Lokitz ML; Billet S; Patel P; Kwon EJ; Sayre RM; Sullivan KE; Werth VP
    Photodermatol Photoimmunol Photomed; 2006 Dec; 22(6):290-6. PubMed ID: 17100736
    [TBL] [Abstract][Full Text] [Related]  

  • 58. IL-1 receptor antagonist attenuates MAP kinase/AP-1 activation and MMP1 expression in UVA-irradiated human fibroblasts induced by culture medium from UVB-irradiated human skin keratinocytes.
    Wang X; Bi Z; Chu W; Wan Y
    Int J Mol Med; 2005 Dec; 16(6):1117-24. PubMed ID: 16273295
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Artificial reproduction of atypical hydRoa vacciniforme caused by latent EpStein-Barr virus infection.
    Heo EP; Park SH; Kim TH
    Int J Dermatol; 2003 Jun; 42(6):476-9. PubMed ID: 12854510
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Actinic reticuloid--an idiopathic photodermatosis with cellular sensitivity to near ultraviolet radiation.
    Botcherby PK; Magnus IA; Marimo B; Giannelli F
    Photochem Photobiol; 1984 May; 39(5):641-9. PubMed ID: 6739556
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.